Literature DB >> 11164080

Beta-1 adrenoceptor antagonists potentiate the anticonvulsive effect of swim stress in mice.

D Pericic1, M Jazvinscak, D Svob, K Mirkovic.   

Abstract

To explore the possible involvement of beta adrenoceptor antagonists in the previously observed anticonvulsive effect of swim stress, the mice were, prior to administration of convulsants, pre-treated with propranolol (a non-selective beta adrenoceptor antagonist), betaxolol (a selective beta-1 adrenoreceptor antagonist), or ICI 118,551 (a selective beta-2 adrenoreceptor antagonist). In control unstressed animals, only propranolol [10 mg/kg, intraperitoneally (ip)] produced a significant change. It enhanced the threshold dose of picrotoxin producing tonic hindlimb extension. However, in swim-stressed animals, propranolol enhanced doses of picrotoxin producing tonic hindlimb extension and death, while betaxolol (20 mg/kg, i.p.) enhanced doses of picrotoxin producing running/bouncing clonus, tonic hindlimb extension and death. Pre-treatment with ICI 118,551 (4 mg/kg, i.p.) failed to affect doses of picrotoxin producing convulsions and death. The results demonstrate that blockade of beta-1 adrenoceptors potentiates the anticonvulsant effect of swim stress against convulsions produced by picrotoxin, a noncompetitive GABA(A) receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11164080     DOI: 10.1016/s0091-3057(00)00385-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

Review 1.  Stress and Seizures: Space, Time and Hippocampal Circuits.

Authors:  B G Gunn; T Z Baram
Journal:  Trends Neurosci       Date:  2017-09-12       Impact factor: 13.837

2.  Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Monika Rudkowska
Journal:  Pharmacol Rep       Date:  2019-12-20       Impact factor: 3.024

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.